Kimball Electronics Inc. reported net sales of USD 341.3 million for the second quarter ended December 31, 2025, representing a 5% decrease year-over-year. The company’s gross margin rate for the quarter was 8.2%, an improvement of 1.6 percentage points compared to the same period in the previous fiscal year. Sales in the medical vertical reached USD 96 million, with continued strong double-digit year-over-year growth in this segment, offset by declines in the automotive and industrial sectors. Cash from operations was positive for the eighth consecutive quarter. Adjusted selling and administrative expenses for the second quarter totaled USD 12.6 million, an increase of USD 2.5 million year-over-year. Kimball Electronics Inc. highlighted momentum in its medical contract manufacturing operations, leveraging expanded capabilities and investments, including the grand opening of a new medical manufacturing facility in Indianapolis. The company also announced a phased rebrand to Kimball Solutions, beginning July 2026, with the official name change pending share owner approval. This strategic shift aims to reflect the company’s commitment to innovation and an expanded portfolio of comprehensive solutions for global markets.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kimball Electronics Inc. published the original content used to generate this news brief on February 05, 2026, and is solely responsible for the information contained therein.